查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405757

药物研发发现资讯学市场规模、份额、趋势分析报告：按工作流程、服务、区域、细分市场预测，2023-2030

Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Workflow (Discovery Informatics, Biocontent Management), By Services (Sequence Analysis Platform), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

药物研发发现资讯学市场的成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球药物研发发现资讯学市场规模预计将达到68.6亿美元，2023年至2030年复合年增长率为11.2%。

近年来，由于快速药物设计和合成、有效追踪疾病进展以及资料完整性管理等多种优势，使用药物研发软体获取市场资讯已受到研究人员的欢迎，其数量显着增加，并正在推动药物发现的成长。行业。

对新型分子不断增长的需求正在推动资讯学解决方案的采用，这些解决方案旨在透过目标大分子相互作用来识别合理的药物分子，从而加速整个药物研发过程。在该市场运营的公司正在获得财务支持，以扩大其药物研发平台，进一步补充市场成长。例如，2020年9月，Aldigen与国家研发中心签署协议，获得开发新技术的经费。

该技术旨在彻底改变基于 T 细胞受体的免疫肿瘤治疗方法的开发。 Ardigen 先前开发了新抗原预测平台ArdImmune Vax，这是一种即用型人工智慧(AI) 和生物资讯解决方案，用于识别最佳新抗原作为过继性细胞疗法和癌症疫苗的标靶。我们正在扩展。此外，化学资讯学解决方案在过去一年中获得了巨大的关注，特别是在满足与最近的 COVID-19 大流行相关的需求方面。

例如，在2021年1月进行的一项研究中，为了加速寻找SARS-CoV-2 Mpro抑制剂，对SARS-CoV主要蛋白酶（Mpro）抑制剂历史活性资料进行了化学数字资料，并介绍了该解决方案的应用。此外，QSAR 模型对于快速药物研发的分子资料探勘很有用。因此，加速 COVID-19 药物开发的需求预计将推动未来几年的产业扩张。

药物研发发现资讯学市场报告亮点

  • 由于临床阶段中的候选药物数量不断增加，预计从 2022 年到 2030 年，药物开发工作流程领域的年复合成长率(CAGR)。
  • 到 2022 年，药物研发发现资讯学领域将占最大收益占有率，约 60%，主要关注精准医疗的开发。精准医学的核心是提供根据个人遗传和分子特征量身定制的个人化医疗。
  • 由于主要市场参与者的存在以及成熟的研发基础设施，以美国主导在 2022 年引领全球市场。
  • 主要市场参与企业都将重点放在策略性收购上，以维持市场竞争。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章药物研发发现资讯学市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 药物研发资讯学市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章药物研发发现资讯学：工作流程估计与趋势分析

  • 药物研发发现资讯学市场：重点
  • 药物研发发现资讯学市场：2022 年和 2030 年趋势和市场占有率分析
  • 发现资讯学
  • 生物含量管理

第五章药物研发发现资讯学：服务估计与趋势分析

  • 药物研发发现资讯学市场：重点
  • 药物研发发现资讯学市场：2022 年和 2030 年趋势和市场占有率分析
  • 序列分析平台
  • 分子建模
  • 对接
  • 临床试验资料管理
  • 其他的

第六章药物研发资讯市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的药物研发资讯市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • Certara
    • Boehringer Ingelheim International GmbH
    • Infosys Ltd.
    • Charles River Laboratories
    • Collaborative Drug Discovery, Inc.
    • Eurofins DiscoverX Products
    • Jubilant Biosys
    • Selvita
    • Novo Informatics Pvt. Ltd.
    • ChemAxon Ltd.
    • Albany Molecular Research Inc.
    • Oracle
    • Accenture
    • Agilent Technologies, Inc.
    • Illumina, Inc.
Product Code: 978-1-68038-749-0

Drug Discovery Informatics Market Growth & Trends:

The global drug discovery informatics market size is expected to reach USD 6.86 billion by 2030, registering a CAGR of 11.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth.

The growing demand for novel molecules is driving the adoption of informatics solutions targeted towards speeding up the entire drug discovery process by identifying rational drug molecules via the target macromolecule interaction. Companies operating in the market are receiving funding for expanding their drug discovery platforms, further supplementing the market growth. For instance, in September 2020, Ardigen signed an agreement with the National Centre for Research and Development to access its funding for developing novel technology.

This technology was aimed at revolutionizing the development of T-cell receptors-based therapies for immuno-oncology. Ardigen has previously developed a neoantigen prediction platform namely, ArdImmune Vax, which deploys ready-to-use Artificial Intelligence (AI) and bioinformatics solutions for the identification of optimal sets of neoantigens as targets for adoptive cell therapies and cancer vaccines. In addition, chemical informatics solutions have gained considerable traction in the past year, particularly in addressing the needs associated with the recent COVID-19 pandemic.

For instance, a research study performed in January 2021 showcased the application of chemical digital solutions in accelerating the search of SARS-CoV-2 Mpro inhibitors by data analysis of previous activity data of SARS-CoV main protease (Mpro) inhibitors. In addition, the QSAR models helped in the data mining of molecules for rapid COVID-19 drug discovery. Hence, the need to facilitate drug development for COVID-19 is expected to propel the industry expansion over the coming years.

Drug Discovery Informatics Market Report Highlights:

  • The drug development workflow segment is projected to exhibit the highest compound annual growth rate (CAGR) of 10.9% from 2022 to 2030 owing to a rise in the number of drug candidates in the clinical development phase
  • The discovery informatics segment accounted for the largest revenue share of around 60% in 2022, with a major focus on developing precision medicines. Precision medicine revolves around providing personalized medical care tailored to an individual's genetic and molecular profile.
  • Led by the U.S., North America led the global market in 2022 due to the presence of key market players and established R&D infrastructure in the country
  • Key industry participants focus on strategic acquisitions to sustain the market competition

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Workflow
    • 1.1.2. Services
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Workflow outlook
    • 2.2.2. Services outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Discovery Informatics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Drug Discovery Informatics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Drug Discovery Informatics: Workflow Estimates & Trend Analysis

  • 4.1. Drug Discovery Informatics Market: Key Takeaways
  • 4.2. Drug Discovery Informatics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Discovery Informatics
    • 4.3.1. Discovery Informatics market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Biocontent Management
    • 4.4.1. Biocontent Management market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Drug Discovery Informatics: Services Estimates & Trend Analysis

  • 5.1. Drug Discovery Informatics Market: Key Takeaways
  • 5.2. Drug Discovery Informatics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Sequence Analysis Platform
    • 5.3.1. Sequence analysis platform market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.4. Molecular Modelling
    • 5.4.1. Molecular Modelling market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Docking
    • 5.5.1. Docking market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.6. Clinical Trial Data Management
    • 5.6.1. Clinical Trial Data Management market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Drug Discovery Informatics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Drug Discovery Informatics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Certara
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Boehringer Ingelheim International GmbH
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Infosys Ltd.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Charles River Laboratories
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Collaborative Drug Discovery, Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Eurofins DiscoverX Products
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Jubilant Biosys
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Selvita
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Novo Informatics Pvt. Ltd.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. ChemAxon Ltd.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Albany Molecular Research Inc.
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Oracle
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Accenture
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Agilent Technologies, Inc.
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Illumina, Inc.
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 3 North America drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 4 North America drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 U.S. drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 7 U.S. drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 8 Canada drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 9 Canada drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 10 Canada drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 11 Europe drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 12 Europe drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 13 Europe drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 14 Germany drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 15 Germany drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 16 Germany drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 17 UK drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 UK drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 19 UK drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 20 France drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 21 France drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 22 France drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 23 Italy drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 24 Italy drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 25 Italy drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 26 Spain drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Spain drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 28 Spain drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 29 Sweden drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 30 Sweden drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 31 Sweden drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 32 Norway drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 33 Norway drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 34 Norway drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 35 Denmark drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 36 Denmark drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 37 Denmark drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 41 China drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 42 China drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 43 China drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 45 Japan drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 46 Japan drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 47 India drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 48 India drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 49 India drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 50 Thailand drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Thailand drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 52 Thailand drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 53 South Korea drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 54 South Korea drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 55 South Korea drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 56 Latin America drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 57 Latin America drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 58 Latin America drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 59 Brazil drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 60 Brazil drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 61 Brazil drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 62 Mexico drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 63 Mexico drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 64 Mexico drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 65 Argentina drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 66 Argentina drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 67 Argentina drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 68 Middle East and Africa drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 69 Middle East and Africa drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 70 Middle East and Africa drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 71 South Africa drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 South Africa drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 73 South Africa drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 74 Saudi Arabia drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 75 Saudi Arabia drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 76 Saudi Arabia drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 77 UAE drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 78 UAE drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 79 UAE drug discovery informatics market, by region, 2018 - 2030 (USD Million)
  • Table 80 Kuwait drug discovery informatics market, by workflow, 2018 - 2030 (USD Million)
  • Table 81 Kuwait drug discovery informatics market, by services, 2018 - 2030 (USD Million)
  • Table 82 Kuwait drug discovery informatics market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig.1 Market research process
  • Fig.2 Data triangulation techniques
  • Fig.3 Primary research pattern
  • Fig.4 Market research approaches
  • Fig.5 Value-chain-based sizing & forecasting
  • Fig.6 QFD modeling for market share assessment
  • Fig.7 Market formulation & validation
  • Fig.8 Drug Discovery Informatics s: market outlook
  • Fig.9 Drug Discovery Informatics s competitive insights
  • Fig.10 Parent market outlook
  • Fig.11 Related/ancillary market outlook
  • Fig.12 Penetration and growth prospect mapping
  • Fig.13 Industry value chain analysis
  • Fig.14 Drug Discovery Informatics market driver impact
  • Fig.15 Drug Discovery Informatics market restraint impact
  • Fig.16 Drug Discovery Informatics market strategic initiatives analysis
  • Fig.17 Drug Discovery Informatics market: Workflow movement analysis
  • Fig.18 Drug Discovery Informatics market: Workflow outlook and key takeaways
  • Fig.19 Discovery informatics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.20 Biocontent management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.22 Drug Discovery Informatics market: Services movement analysis
  • Fig.23 Drug Discovery Informatics market: Services outlook and key takeaways
  • Fig.24 Sequence analysis platforms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.25 Molecular modelling market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.26 Docking market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.27 Clinical trial data management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.29 Global Drug Discovery Informatics market: regional movement analysis
  • Fig.30 Global Drug Discovery Informatics market: regional outlook and key takeaways
  • Fig.31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.37 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.40 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.41 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.44 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.45 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.46 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.48 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.49 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.52 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.53 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.56 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.57 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig.58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)